Impact of Medjool Date Consumption on Labor and Delivery Outcomes

Completed · Not applicable

Conditions studied: Spontaneous Labor

In brief

The proposed Medjool date randomized trial will help inform clinical practice regarding the utility of Medjool date consumption for labor onset by comparing the incidence of spontaneous labor with the need for labor induction in patients who have been randomized to consume Medjool dates from 34 weeks gestation through the day after delivery day. The study will secondarily investigate the relationship between date consumption and other important labor and delivery outcomes such as length of labor, need for oxytocin, dose of oxytocin and quantitative blood loss at delivery. This study will also explore the association between Medjool date consumption, perinatal hemoglobin levels, and perinatal diet quality. Assessing dietary intake is an essential component of this study to better understand the relationship between medjool date consumption and pregnancy/labor outcomes by controlling for it as a potential confounding factor. Furthermore, assessing dietary intake will provide insight on the impact medjool date consumption has on overall maternal diet quality.

Key facts

Study ID

NCT07058792

Run by

The Cleveland Clinic

People needed

200

Starts

2025-02-21

Expected to finish

2026-05-13

Last updated by the study team

2026-08-03

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Singleton pregnancy less than 36weeks 0 days gestational age
• Age ≥18 years old
• Has decision-making capacity and able to provide informed consent for research participation
• Able to speak, read and understand English
• Planned delivery at a Cleveland Clinic Institution

You may not qualify if…

• Pre-existing medical co-morbidities including hypertension, kidney disease, autoimmune conditions, diabetes
• Comorbidities of pregnancy including hypertensive disorders of pregnancy and gestational diabetes
• Abnormal genetic (aneuploidy) screening or diagnostic testing
• Patients with pregnancies complicated by major fetal anomalies
• Multifetal gestation
• Delivery at an outside institution
• Incomplete delivery data
• Planned cesarean delivery
• Planned induction of labor prior to 41 weeks

Where it is running

• Cleveland Clinic — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.